Condition
Parathyroid Hyperplasia
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Withdrawn1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04299425Not ApplicableCompleted
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
NCT03027557Phase 3Completed
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
NCT03469310Phase 4Completed
Minimizing Narcotic Analgesics After Endocrine Surgery
NCT02636075UnknownPrimary
"Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"
NCT01421407Not ApplicableWithdrawn
Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism
Showing all 5 trials